Tamoxifen-Dependent Induction of AGR2 Is Associated with Increased Aggressiveness of Endometrial Cancer Cells.

Logo poskytovatele

Varování

Publikace nespadá pod Filozofickou fakultu, ale pod Přírodovědeckou fakultu. Oficiální stránka publikace je na webu muni.cz.
Autoři

HRSTKA Roman PODHOREC Ján NENUTIL Rudolf SOMMEROVÁ Lucia OBACZ Joanna Agnieszka ĎURECH Michal FAKTOR Jakub BOUCHAL Pavel SKOUPILOVÁ Hana VOJTĚŠEK Bořivoj

Rok publikování 2017
Druh Článek v odborném periodiku
Časopis / Zdroj Cancer Investigation
Fakulta / Pracoviště MU

Přírodovědecká fakulta

Citace
www http://dx.doi.org/10.1080/07357907.2017.1309546
Doi http://dx.doi.org/10.1080/07357907.2017.1309546
Klíčová slova AGR2; Breast cancer; Endometrial cancer; Tamoxifen
Popis Tamoxifen treatment in breast cancer patients is associated with increased risk of endometrial malignancies. Significantly, higher AGR2 expression was found in endometrial cancers that developed in women previously treated with tamoxifen compared to those who had not been exposed to tamoxifen. An association of elevated AGR2 level with myometrial invasion occurrence and invasion depth was also found. In vitro analyses identified a stimulatory effect of AGR2 on cellular proliferation. Although adverse tamoxifen effects on endometrial cells remain elusive, our work identifies elevated AGR2 as a candidate tamoxifen-dependent mechanism of action responsible for increased incidence of endometrial cancer.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.